
MedTech Product vCISO · Fractional Product Security Officer
Ongoing advice from a fractional product cybersecurity officer for your medical device, software, apps, and cloud. Product security, not general company IT security.
Starting at $5,000 a month
Final monthly fee is fixed after scoping. Up to 20 hours a month of expert access.
A MedTech vCISO retainer gives your team recurring product-security advice without adding a full-time role. Our Fractional Product Security Officer helps review architecture changes, secure-development practices, vulnerability decisions, and cybersecurity evidence. Agree priorities and a communication cadence around your device and team.
Blue Goat advises and recommends. Your engineering, regulatory, and quality teams retain product changes, clinical-risk evaluation, risk acceptance, release approval, and submission decisions.
Need one project instead? Standalone cybersecurity consulting remains available. No monthly retainer is required.
Agreed advisory meetings, design and document reviews, vulnerability review, and written recommendations or summaries. Specific artifacts and larger projects are identified separately.
Discuss architecture changes, security requirements, connected-system boundaries, and priorities with an experienced product-security advisor.
Review existing cybersecurity records, identify gaps, and plan separately scoped threat modeling, SBOM work, testing, and premarket evidence.
Plan secure-development responsibilities and how cybersecurity records connect to your quality procedures. SOP authoring and rollout projects require separate agreement.
Discuss component advisories, release changes, disclosure processes, and patch-planning decisions. Monitoring operations and engineering fixes are not automatically included.
Monthly retainer
Final monthly fee is fixed after scoping.
Scoped consulting projects receive a fixed-fee quote after scoping. Optional retainer: Starting at $5,000 a month. Final monthly fee is fixed after scoping. The retainer provides up to 20 hours a month of expert access. Larger projects require separate agreement.
The written agreement names the product boundary, recurring activities, priorities, inputs, and communication cadence. Additional work requires a separately agreed scope change. There is no automatic inclusion of every cybersecurity deliverable.
275+ FDA submissions supported, zero cybersecurity rejections. This describes prior work, not a promise about a future submission.
No. This role focuses on medical-device product cybersecurity: design decisions, development practices, vulnerability reviews, and cybersecurity evidence. General company IT security and enterprise CISO duties are outside the retainer.
When your team needs recurring advice across design changes, submission planning, and postmarket decisions. A standalone consulting project may fit better when you need one defined deliverable. We agree the product boundary and recurring activities before quoting.
This is the name of our advisory role, not a claim that every manufacturer must hire one. Our Fractional Product Security Officer advises on device cybersecurity. The manufacturer retains its regulatory responsibilities, risk acceptance, and release decisions.
Not automatically. It can help plan and review these activities. A threat model, SBOM, or penetration test requires a separately agreed scope. Larger document projects and QMS/SOP work also require separate agreement.
The manufacturer. Blue Goat provides product-security advice and recommendations. Your engineering, regulatory, and quality teams own clinical-risk evaluation, risk acceptance, product changes, release approval, and submissions.
More questions? Read our medical device cybersecurity FAQs.
Tell us about your product, its stage, and the recurring help your team needs. Sending an inquiry does not reserve a meeting or commit you to a retainer.
Book a free 30-minute discovery call. Your meeting is confirmed when you complete the calendar booking. Keep confidential device details out of booking notes.
Share a brief, non-confidential description. We agree scope before quoting.